6,678 trials
HIV · Impaired Cognition
Primary: Cognitive Function, Global Cognitive Score (Z-score) — 0.15; 0.19; 0.16; 0.25 z score — p=0.68
Pulmonary Disease, Chronic Obstructive
Primary: Percentage of Participants Making at Least One Critical Error After Reading the Patient Information Leaflets (PIL) — 9; 75; 9; 73 Percentage of participants — p=<0.001
Renal Transplant Rejection · Immunosuppression
Primary: Cytokines Evaluation — 380; 893; 763; 147 MFI — p=<0.05
Total Hip and Knee Arthroplasty
Primary: Pain Score — 3.78; 3.85; 3.3; 3.4 score on a scale
Fertility · Contraception
Primary: Median Cervical Mucus Score - Baseline — 11; 13 score on a scale
Contraception
Primary: Percentage of Successful Self-Injections Performed of All Attempts at Home on Schedule (Full Analysis Set) — 88.8 Percentage of all attempts at home
Mild Cognitive Impairment (MCI) · Depression
Primary: Change in Hamilton Depression Rating Scale — 17.8; 17.7; 6.0; 6.7 units on a scale
Multiple Myeloma
Primary: Complete Response Rate — 7; 7 Participants
Type 2 Diabetes · Dyslipidemia
Primary: Hepatic Fatty Acid Oxidation — 0.052; 0.045; 0.042 micromol/ml/min
Urinary Tract Infection · Recurrent Urinary Tract Infection
Primary: Changes to the Urinary Microbiota — 3; 2; 1 participants
Expectancy Versus Pharmacotherapy Effect of Adderall
Primary: Number of Participants Consistently Attending and Completing Four Neuroimaging Sessions — 4; 4; 4; 4 Participants
Atopic Dermatitis
Primary: Number of Participants With Treatment Emergent Adverse Events (AEs), Serious Adverse Events (SAEs) and Site Reactions — 88; 1; 15 Participants
Infertility
Primary: Clinical Pregnancy Rate — 36.93; 39.66 percentage of participants — p=0.49
Emergence Agitation
Primary: Number of Participants With Emergent Agitation — 16; 24 Participants
Pain · Obesity · Hypoxia
Primary: Quality of Recovery 40 — 170; 179 score on a scale